… So, those studies couldn’t represent the status of dyslipidemia in the whole region … dyslipidemia
in Xinjiang, our team did a cross-sectional study called the Cardiovascular Risk Survey (…

… care physicians and 35,869 patients we determined the prevalence of dyslipidemia, its
recognition, treatment, and control rates. Diagnosis of dyslipidemia was based on TC and LDL-C. …

… surveys have been carried out among physicians and patients on the estimation of cardiovascular
risk… on CVR, comorbidities, degree of control, and drug treatment used and its safety. …

… disease (CVD). We aimed to investigate the association of dyslipidemia and CVD events
among … on reducing modifiable CVD risk factors to control the rising prevalence of CVD and its …

… monotherapy in about 3300 patients with established vascular disease and mixed dyslipidemia
and HPS2-Thrive (Heart Protection Study-Treatment of HDL to Reduce the Incidence of …

… , which only mentions “family history of coronary artery disease,” is not specific enough to …
of CVD risk factors for dyslipidemia on the basis of treatment guidelines graded by CV risk level…

… which have the potential to revolutionize the treatment of elevated Lp(a) and improve our
ability to treat residual cardiovascular risk in patients with otherwise well-controlled risk factors. …

… TO THE EDITOR: The paper by Patel and colleagues used data from 50 states plus the
District of Columbia to develop a model to explain risk factors for cardiovascular disease (CVD) …

… heart disease and cerebrovascular disease represent the most significant expressions of
cardiovascular disease, … in the year 2001 (American Heart Association, 2003). According to the …

… Clinical guidelines and evidence review for lipid modification: cardiovascular risk
assessment and the primary and secondary prevention of cardiovascular disease. National …